Company Analysis
Sign in

Telix Pharmaceuticals Limited (TLX)

Nasdaq: TLX · Pharmaceutical Preparations · North Melbourne, AU · filing with the SEC since 2024
Full chart Alerts Compare
Grade6.6
◀ Past 7.7● Present 6.8▶ Future 5.2
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

6 patents granted to the 8 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Telix Pharmaceuticals Limited’s names, not what it holds today.

Patents granted
6
6 utility, 1976 to Dec 31, 2025
Granted in 2025
3
Against 3 in 2024 and none in 2023
Applications published
13
4 of them in 2025
Names they are printed under
8
a subsidiary, its own name
By yearGrantedApplications published
'22'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology2
Chemical engineering1
Control1
Pharmaceuticals1
Organic fine chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name8 counted
Lightpoint Surgical Ltd a subsidiary
GB, as the owner printed on each patent
3 granted
1 published
TELIX PHARMACEUTICALS (INNOVATIONS) PTY LTD a subsidiary
named as the applicant on its applications, in AU
0 granted
4 published
Telix Innovations S.A. a subsidiary
BE, as the owner printed on each patent
1 granted
3 published
Telix ARTMS Inc. a subsidiary
named as the applicant on its applications, in CA
0 granted
2 published
Telix Pharmaceuticals Limited its own name
AU, as the owner printed on each patent
1 granted
1 published
Telix ARTMS Inc. a subsidiary
CA, as the owner printed on each patent
1 granted
0 published
Telix Innovations SA a subsidiary
named as the applicant on its applications, in BE
0 granted
1 published
Telix Pharmaceuticals (Innovations) Pty Ltd. a subsidiary
AU, as the owner printed on each patent
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Aug 12, 202512,383,636Marking precursor with squaric acid couplingOrganic fine chemistryTelix Pharmaceuticals Limited
Jun 17, 202512,329,829Kit for radiolabelling with 68GA comprising a metal inhibitorPharmaceuticalsTelix Innovations S.A.
Jan 21, 202512,205,490Apparatus for simulating radio-guided surgeryControlLightpoint Surgical Ltd
Oct 22, 202412,121,828Systems and methods of isolation of gallium-68Chemical engineeringTelix ARTMS Inc.
Aug 27, 202412,070,238Tethered laparoscopic probe gripMedical technologyLightpoint Surgical Ltd
Apr 23, 202411,963,807Tethered laparoscopic probeMedical technologyLightpoint Surgical Ltd
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 27, 20252025/0360235RADIOLABELLING KIT AND METHOD FOR RADIOLABELLINGPharmaceuticalsTelix Innovations SA
Sep 18, 20252025/0288702LABELING PRECURSORS WITH SQUARIC ACID COUPLINGOrganic fine chemistryTelix Pharmaceuticals Limited
Aug 7, 20252025/0249381SYSTEMS AND METHODS OF ISOLATION OF GALLIUM-68Chemical engineeringTelix ARTMS Inc.
Jan 9, 20252025/0009911DOTA-HYNIC-iPSMA AS A THERAPEUTIC RADIOPHARMACEUTICAL TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGENPharmaceuticalsTelix Innovations S.A.
Nov 28, 20242024/0390818SYSTEMS AND METHODS OF ISOLATION OF GALLIUM-68Chemical engineeringTelix ARTMS Inc.
Nov 14, 20242024/0374764COMBINATION RADIOTHERAPYPharmaceuticalsTelix Pharmaceuticals (Innovations) Pty Ltd.
Nov 7, 20242024/0366780PREPARATORY PROCESSPharmaceuticalsTELIX PHARMACEUTICALS (INNOVATIONS) PTY LTD
Oct 31, 20242024/0359144AGGREGATE SEPARATION METHODBiotechnologyTELIX PHARMACEUTICALS (INNOVATIONS) PTY LTD
Oct 17, 20242024/0342323ANTIBODIES AGAINST CAIX WITH REDUCED AFFINITY FOR THE NEONATAL FC RECEPTORPharmaceuticalsTELIX PHARMACEUTICALS (INNOVATIONS) PTY LTD
Oct 17, 20242024/0341794TETHERED LAPAROSCOPIC PROBE GRIPMedical technologyLightpoint Surgical Ltd
What it applied for, 2024 to 2025: Pharmaceuticals 5 · Organic fine chemistry 2 · Chemical engineering 2 · Medical technology 1 · Biotechnology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton TLX · research, not advice